Nativa analyze the presence of trisomy 21, 18 or 13, sexual chromosomes aneuploidy and the sex of the unborn.
Nativa can analyze the presence of the following chromosomal anomalies:
The whole Nativa workflow is CE-IVD marked (In-Vitro Diagnostic) and is performed into the SmeL accredited (Lombardy Region Clinical Laboratory Services) BioRep laboratory, located at the San Raffaele Hospital Scientific Park in Milan. European Community certify that NATIVA is conformed to the European standards and performance levels for medical devices. The CE-IVD mark is issued only if the product is compliance to the 98/79/CE legislation and it’s a guarantee of quality.
Nativa is suitable for every pregnant woman that want to avoid the miscarriage risks from invasive diagnosis. Nativa can be performed from the 10th week of gestation.
Nativa is suited also for:
Nativa is particularly suited in case of:
LIMITS of the TEST
In case of twin pregnancies NATIVA:
Nativa cannot be used in case of multiple pregnancies with more than 2 fetus.